Your browser doesn't support javascript.
loading
Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma.
Eskelund, Christian Winther; Albertsson-Lindblad, Alexandra; Kolstad, Arne; Laurell, Anna; Räty, Riikka; Pedersen, Lone Bredo; Geisler, Christian Hartmann; Jerkeman, Mats; Grønbæk, Kirsten.
Afiliación
  • Eskelund CW; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Albertsson-Lindblad A; Biotech Research and Innovation Centre, Copenhagen, Denmark.
  • Kolstad A; Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Oncology and Pathology, Sweden.
  • Laurell A; Department of Oncology, Oslo University Hospital, Norway.
  • Räty R; Department of Oncology, Uppsala University Hospital, Sweden.
  • Pedersen LB; Department of Hematology, Helsinki University Hospital, Finland.
  • Geisler CH; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Jerkeman M; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Grønbæk K; Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Oncology and Pathology, Sweden.
Haematologica ; 103(11): e541-e543, 2018 11.
Article en En | MEDLINE | ID: mdl-29794145

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteína p53 Supresora de Tumor / Linfoma de Células del Manto / Mutación Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2018 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteína p53 Supresora de Tumor / Linfoma de Células del Manto / Mutación Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2018 Tipo del documento: Article País de afiliación: Dinamarca